Related Experiment Video
Updated: Sep 3, 2025

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Total Synthesis of Darobactin A
Marko Nesic1, David B Ryffel1, Jonathan Maturano1
1Department of Chemistry and Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois61801, United States.
Researchers achieved the total synthesis of darobactin A, a novel antibiotic targeting Gram-negative bacteria. This efficient synthesis utilized scalable routes for non-canonical amino acids and sequential Larock indole cyclizations for the bismacrocycle.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Synthetic Biology
Background:
- Darobactin A is a recently discovered antibiotic with selective activity against Gram-negative bacteria.
- The complex structure of darobactin A presents a significant challenge for chemical synthesis.
- Targeting Gram-negative bacteria is crucial due to rising antibiotic resistance.
Purpose of the Study:
- To achieve the total synthesis of darobactin A.
- To develop scalable synthetic routes for key building blocks, including non-canonical amino acids.
- To explore and optimize cyclization strategies for constructing the bismacrocyclic core.
Main Methods:
- Convergent synthesis strategy.
- Development of scalable routes for three non-canonical amino acids.
- Sequential, halogen-selective Larock indole syntheses for bismacrocycle closure.
Main Results:
- Successful total synthesis of darobactin A accomplished.
- Longest linear sequence of 16 steps achieved from d-Garner's aldehyde and l-serine.
- The order of sequential cyclizations was critical for forming the correct atropisomer.
Conclusions:
- The total synthesis of darobactin A is feasible using a convergent approach.
- The developed methods provide access to a promising new antibiotic scaffold.
- This work validates the utility of sequential Larock indole syntheses in complex molecule construction.
More Related Videos
10:41The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
Published on: January 13, 2013
09:08From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Biosynthesis in Bacteria